Matthew E. Herberg
Papers
1
Total Citations
44
H-Index
1
About
Matthew E. Herberg is a leading surgical oncologist whose research focuses on refining treatment paradigms for HPV-related oropharyngeal squamous cell carcinoma (HPV+ OPSCC). His major contributions center on evaluating the impact of surgical margins in patients undergoing single-modality transoral robotic surgery (TORS), a minimally invasive approach that spares patients the toxicity of adjuvant therapy. In his landmark 2021 study, cited 44 times, Herberg led a multi-institutional retrospective analysis to clarify the oncologic significance of close surgical margins—a contentious issue in HPV+ disease. By demonstrating that margin status does not independently predict local control in this favorable-risk population, his work has helped de-escalate unnecessary adjuvant treatments, reducing morbidity while maintaining excellent outcomes. This research has directly influenced clinical guidelines and surgical decision-making, establishing Herberg as a key voice in the movement toward personalized, de-intensified therapy for HPV+ OPSCC. His findings underscore the importance of tumor biology over traditional histologic metrics, advancing a more nuanced approach to head and neck cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1